
Vodafone Idea Limited Management to Participate in Citi India Conference 2026
Vodafone Idea Limited announced details regarding the participation of its representatives in an upcoming Analyst and Institutional Investor Meeting scheduled for June 5, 2026.The company is participating in the Citi India Conference 2026, a group meeting set to be held in Mumbai on that date. The engagement includes management representation from Vodafone Idea Limited.
The details of the investor conference participation are as follows:
| Date of the Meeting | Name of the Event | Type of Meeting | Location |
|---|---|---|---|
| 5 June 2026 | Citi India Conference 2026 | Group | Mumbai |
Vodafone Idea Limited stated that its management team’s participation in the investor conference was confirmed at short notice. Furthermore, the company noted that no unpublished price sensitive information is proposed to be shared during the aforementioned investor meeting.
IDEA Stock Price Movement
Shares of Vodafone Idea Limited are edging higher to ₹14.27 as of 12:48 PM, rallying by 0.78% in live trading following the upward momentum today. The equity’s ascent is underscored by a massive volume of 361 million shares traded and a significant performance milestone after reaching its 52-week high.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.